DoorDash Sits Near 52-Week Lows as Analysts See Upbeat Long-Term Path
DoorDash sits near 52-week levels after a tough quarter that piled up costs from Deliveroo and grocery pushes. Yet Wa...
Investors follow market indices to gauge performance, set expectations, and benchmark risk. Indices provide a common frame for evaluating results.
28,426 articlesDoorDash sits near 52-week levels after a tough quarter that piled up costs from Deliveroo and grocery pushes. Yet Wa...
Solar’s most hated year is fading into a powerful five-month rally. The Invesco SOLAR ETF has surged roughly 45% sinc...
Two major AI infrastructure players appear attractively priced as heavy investment in AI chips and automation presses...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Goosehead (GSHD) is shaping its 2025 earnings trajectory with a blend of agency growth and tech-enabled efficiency. T...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
Rising capex threatens the cash-flow yields that power popular cash cows. This report explains why and what investors...
Apple’s next AI chapter hinges on Siri. If the so-called this "siri-ous" problem could derail AI progress, investors ...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...
A rising figure in Iran’s shadow government, Mojtaba Khamenei is fueling a debate over who will lead and how the econ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...